Physician

Maryam Ghiassi, MD

According to 2025 Medicare claims, Maryam Ghiassi, MD (NPI: 1346773934) practices ophthalmology in the Vallejo, CA market, with the plurality of this provider's patient population coming from Solano, CA. This provider's primary affiliated billing organization is VITREO-RETINAL MEDICAL GROUP, INC. (NPI: 1114010949; TIN: 942442567) and primary practice location at 95356-9404. Ghiassi is affiliated with the NeueHealth Premier ACO, LLC (ACO ID: D0181) and NeueHealth Community ACO, LLC (ACO ID: D0324), participating under the REACH model.

Ghiassi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,169 traditional Medicare patients, billed 52,084 HCPCS/CPT codes, and received $2,929,099 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 557 prescription claims across 190 beneficiaries totaling $40,950 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 33 records totaling $5,279. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have fallen sharply in recent years, from $1,817 to $40,950. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$2.9M2021 Medicare payment: $14,149 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $18,922 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $292,487 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,929,099 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021130235$14,149
2022145308$18,922
20233233,308$292,487
20241,16952,084$2,929,099

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$35K$71K2017 Drug cost: $1,817 (USD; Tot_Drug_Cst)2018 Drug cost: $6,084 (USD; Tot_Drug_Cst)2019 Drug cost: $70,970 (USD; Tot_Drug_Cst)2020 Drug cost: $34,278 (USD; Tot_Drug_Cst)2021 Drug cost: $34,437 (USD; Tot_Drug_Cst)2022 Drug cost: $8,846 (USD; Tot_Drug_Cst)2023 Drug cost: $5,441 (USD; Tot_Drug_Cst)2024 Drug cost: $40,950 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171538$1,817
201833123$6,084
20191761,132$70,970
2020166789$34,278
2021134699$34,437
202291187$8,846
202361124$5,441
2024190557$40,950

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye365392$146
67028Injection of drug into eye4511,468$107
92014Established patient complete exam of visual system406478$96
92012Established patient problem focused exam of visual system296398$77
92134Imaging of retina1,0542,508$34

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1324,634$6,395
Brimonidine TartrateBrimonidine Tartrate663,826$1,863
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat594,451$1,154
Ketorolac TromethamineKetorolac Tromethamine411,966$1,003
LatanoprostLatanoprost764,572$982

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.33$5,279Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Maryam Ghiassi, MD?

Tedicare shows public-source Medicare data for Maryam Ghiassi, MD (NPI 1346773934), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maryam Ghiassi, MD have ACO affiliation data?

Maryam Ghiassi, MD is shown with ACO affiliation data for NeueHealth Premier ACO, LLC (REACH, ACO ID D0181) and NeueHealth Community ACO, LLC (REACH, ACO ID D0324).

What billing organization is linked to Maryam Ghiassi, MD?

Maryam Ghiassi, MD is linked to VITREO-RETINAL MEDICAL GROUP, INC. (billing NPI 1114010949) in the available physician profile data.

Does Maryam Ghiassi, MD have Open Payments data?

Maryam Ghiassi, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.